Finally, the authors confirmed that the PRDM14-induced mouse tumors share molecular features with human T-ALL, including the expression of high levels of activated NOTCH1, which is mutated in more than 50% of human T-ALL cases. The gene discussed is NOTCH1; the disease is acute lymphoblastic leukemia.